Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Return on Invested Capital (2021 - 2022)

Atea Pharmaceuticals (AVIR) has 2 years of Return on Invested Capital data on record, last reported at 0.05% in Q3 2022.

  • For Q3 2022, Return on Invested Capital changed 0.0% year-over-year to 0.05%; the TTM value through Sep 2022 reached 0.05%, changed 0.0%, while the annual FY2021 figure was 0.19%, N/A changed from the prior year.
  • Return on Invested Capital reached 0.05% in Q3 2022 per AVIR's latest filing, up from 0.02% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.19% in Q4 2021 and bottomed at 0.02% in Q2 2022.